AbbVie Inc.: pre-tax income or loss from continuing operations

What this measure means

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Exact concept: us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2011-01-01 to 2025-12-31. The SEC response was captured on 2026-09-20.

Selected filing history

Related financial histories

• AbbVie Inc.: total assets
• AbbVie Inc.: stockholders equity
• AbbVie Inc.: cash and cash equivalents
• AbbVie Inc.: net income or loss
• AbbVie Inc.: operating cash flow
• AbbVie Inc.: capital expenditure payments
• AbbVie Inc.: revenue
• AbbVie Inc.: contract revenue excluding tax
• AbbVie Inc.: financing cash flow
• AbbVie Inc.: investing cash flow
• AbbVie Inc.: retained earnings or deficit
• AbbVie Inc.: basic weighted-average shares
• AbbVie Inc.: diluted weighted-average shares
• AbbVie Inc.: basic earnings per share
• AbbVie Inc.: diluted earnings per share
• AbbVie Inc.: income tax expense or benefit
• AbbVie Inc.: net property, plant and equipment
• AbbVie Inc.: share-based compensation expense
• AbbVie Inc.: operating income or loss
• AbbVie Inc.: current assets
• AbbVie Inc.: interest expense
• AbbVie Inc.: current liabilities
• AbbVie Inc.: current accounts payable
• AbbVie Inc.: goodwill carrying amount
• AbbVie Inc.: net finite-lived intangible assets
• AbbVie Inc.: net current accounts receivable
• AbbVie Inc.: common-stock repurchase payments
• AbbVie Inc.: net inventory
• AbbVie Inc.: selling, general and administrative expense
• AbbVie Inc.: cash including restricted cash
• AbbVie Inc.: accumulated other comprehensive income or loss
• AbbVie Inc.: total equity including noncontrolling interests
• AbbVie Inc.: operating lease right-of-use asset
• AbbVie Inc.: operating lease liability
• AbbVie Inc.: long-term debt
• AbbVie Inc.: gross property, plant and equipment
• AbbVie Inc.: accumulated depreciation on property, plant and equipment
• AbbVie Inc.: net intangible assets excluding goodwill
• AbbVie Inc.: other noncurrent assets
• AbbVie Inc.: other noncurrent liabilities
• AbbVie Inc.: net deferred tax assets
• AbbVie Inc.: net deferred tax liabilities
• AbbVie Inc.: profit or loss including noncontrolling interests
• AbbVie Inc.: comprehensive income or loss
• AbbVie Inc.: net income available to common stockholders
• AbbVie Inc.: depreciation expense
• AbbVie Inc.: amortization of intangible assets
• AbbVie Inc.: other nonoperating income or expense
• AbbVie Inc.: current income tax expense or benefit
• AbbVie Inc.: deferred income tax expense or benefit
• AbbVie Inc.: interest paid, net
• AbbVie Inc.: income taxes paid, net
• AbbVie Inc.: operating lease payments
• AbbVie Inc.: change in accounts receivable
• AbbVie Inc.: change in inventories

Inspect the source

Entity

AbbVie Inc. / CIK 0001551152

Captured

2026-09-20T09:18:39.120Z

SEC response SHA-256

1fa00a2de3a0434fb2ebba8b1678cc379b16dc435a4f3e5c696efb7f9029698a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001551152.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))